10 Stocks With at Least 10% Projected Returns in 2013


This Says Our Favorite Biotech Is Off to the Races

Shares of a promising biotech we recommended back in February 2013 – jumped as much as 27% to a three-month high of $14.20 yesterday after the company said a new cancer drug met its main goal in a midstage clinical trial.

Its shares backtracked a bit as the day progressed but still closed 17.6% higher for the session. These shares have advanced 361% since we first told you about them. The stock has generated a peak gain of 456%, making it one of the 31 recommendations we’ve made to you that have doubled or better since we launched Private Briefing in August 2011. (More on that later…)

It doesn't hurt to have help narrowing down the best stocks to buy...

Especially when that "help" comes from one of the most successful stock analysts in the country.

Tobias Levkovich, Citigroup Inc.'s (NYSE:C) chief equity strategist, sent a note to clients consisting of 18 recommended stocks and their end-of-year price targets. We've sifted through the list to bring you the 10 stocks that have the highest projected returns based on Citi's targets - ranging from 10.14% to 27.27%.

Here are the 10 companies and their 2013 price targets, along with a summary of Citi's analysis for each stock...

The remaining content is exclusively for Money Morning subscribers. To gain access, enter your email address:

(After submitting your email address the page will refresh with the full article. You will receive a welcome email from Money Morning including the benefits of your free subscription.)